Shares of PureTech Health plc (NASDAQ:PRTC – Get Free Report) gapped down prior to trading on Monday . The stock had previously closed at $28.47, but opened at $27.15. PureTech Health shares last traded at $27.15, with a volume of 465 shares trading hands.
PureTech Health Price Performance
The stock’s 50-day moving average is $27.14 and its 200 day moving average is $24.05.
PureTech Health Company Profile
PureTech Health plc, a clinical stage biotherapeutics company, engages in the discovery, development, and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, currently under Phase 3 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, to inhibit the activity of galectin-9 for treating solid tumors and hematological malignancies.
Featured Stories
- Five stocks we like better than PureTech Health
- How to Calculate Stock Profit
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- Stock Analyst Ratings and Canadian Analyst Ratings
- Generac Powers Ahead on the Electrification Mega-Trend
- Most active stocks: Dollar volume vs share volume
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.